|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2022
Fromme, Hermann; Fuchs, Veronika; Albrecht, Michael; Aschenbrenner, Bettina; Roehl, Claudia; Janitzki, Nora; Herber-Jonat, Susanne; Woeckner, Mandy; Voelkel, Wolfgang; Flemmer, Andreas W. und Schober, Wolfgang
(2022):
Polychlorinated dioxins and dibenzofurans (PCDD/F), polybrominated dioxins and dibenzofurans (PBDD/F), polychlorinated biphenyls (PCB), polybrominated diphenyl ethers (PBDE), and per- and polyfluoroalkyl substances (PFAS) in German breast milk samples (LUPE 8).
In: Science of the Total Environment, Bd. 825, 154066
2020
Li, Zhong-Min; Albrecht, Michael; Fromme, Hermann; Schramm, Karl-Werner und De Angelis, Meri
(2020):
Persistent Organic Pollutants in Human Breast Milk and Associations with Maternal Thyroid Hormone Homeostasis.
In: Environmental Science & Technology, Bd. 54, Nr. 2: S. 1111-1119
2016
Fromme, Hermann; Hilger, Bettina; Albrecht, Michael; Gries, Wolfgang; Leng, Gabriele und Völkel, Wolfgang
(2016):
Occurrence of chlorinated and brominated dioxins/furans, PCBs, and brominated flame retardants in blood of German adults.
In: International Journal of Hygiene and Environmental Health, Bd. 219, Nr. 4-5: S. 380-388
2015
Bergmann, Lothar; Kube, Ulrich; Doehn, Christian; Steiner, Thomas; Goebell, Peter J.; Kindler, Manfred; Herrmann, Edwin; Janssen, Jan; Weikert, Steffen; Scheffler, Michael T.; Schmitz, Jörg; Albrecht, Michael und Staehler, Michael
(2015):
Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study.
In: BMC Cancer
15:303
[PDF, 1MB]
2013
Bergmann, Lothar; Goebell, Peter J.; Kube, Ulrich; Kindler, Manfred; Herrmann, Edwin; Janssen, Jan; Schmitz, Joerg; Weikert, Steffen; Steiner, Gabriel; Jakob, Andreas; Staehler, Michael D.; Steiner, Thomas; Overkamp, Friedrich; Albrecht, Michael; Guderian, Gernot und Doehn, Christian
(2013):
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study.
In: Onkologie, Nr. 3: S. 95-100
[PDF, 441kB]